How CAR T cells can be shielded from prostaglandin E2 signaling to enhance their therapeutic activity.
- DOI
- 10.1016/j.omton.2026.201204
- Published
- 2026 Jun 18
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2026.201204,
title = {How CAR T cells can be shielded from prostaglandin E2 signaling to enhance their therapeutic activity.},
author = {Dörr J and Andreu-Sanz D and Kobold S},
year = {2026},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2026.201204},
url = {https://doi.org/10.1016/j.omton.2026.201204}
}RIS
TY - JOUR TI - How CAR T cells can be shielded from prostaglandin E2 signaling to enhance their therapeutic activity. AU - Dörr J AU - Andreu-Sanz D AU - Kobold S PY - 2026 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2026.201204 UR - https://doi.org/10.1016/j.omton.2026.201204 ER -
APA
J, D., D, A., & S, K. (2026). How CAR T cells can be shielded from prostaglandin E2 signaling to enhance their therapeutic activity.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201204
Source records
- pubmed · retrieved 2026-09-25T08:53:10.320Z